Table of Contents

Article

• • A pharmacologic overview of current and emerging anticoagulants

    Edith A. Nutescu, PharmD, Nancy L. Shapiro, PharmD, Aimee Chevalier, PharmD and Alpesh N. Amin, MD, MBA

    • Cleveland Clinic Journal of Medicine April 2005, 72 (4 suppl 1) S2-S6;
  • Prevention of venous thromboembolism in medical and surgical patients

    Peter J. Kaboli, MD, Adam Brenner, BS and Andrew S. Dunn, MD

    • Cleveland Clinic Journal of Medicine April 2005, 72 (4 suppl 1) S7-S13;
  • Current and emerging options in the management of venous thromboembolism

    Amir K. Jaffer, MD, Daniel J. Brotman, MD and Franklin Michota, MD

    • Cleveland Clinic Journal of Medicine April 2005, 72 (4 suppl 1) S14-S23;
  • Stroke prevention in atrial fibrillation

    Benjamin T. Fitzgerald, MBBS, Steven L. Cohn, MD and Allan L. Klein, MD

    • Cleveland Clinic Journal of Medicine April 2005, 72 (4 suppl 1) S24-S30;
  • Heparin-induced thrombocytopenia

    John R. Bartholomew, MD, Susan M. Begelman, MD and Amjad Almahameed, MD

    • Cleveland Clinic Journal of Medicine April 2005, 72 (4 suppl 1) S31-S36;
  • Anticoagulation in special patient populations

    Franklin Michota, MD and Geno Merli, MD

    • Cleveland Clinic Journal of Medicine April 2005, 72 (4 suppl 1) S37-S42;
  • Cost considerations surrounding current and future anticoagulant therapies

    Margaret C. Fang, MD, MPH, Tracy Minichiello, MD and Andrew D. Auerbach, MD, MPH

    • Cleveland Clinic Journal of Medicine April 2005, 72 (4 suppl 1) S43-S49;